Skip to main content

Cardiology

Editor's Choice

Is heart failure a risk factor for cancer?

The causal effect of cancer and cancer therapies on the development of heart failure is well known, but what about the other way around? Explore the evidence for the pathophysiological pathways linking tumor growth with heart failure.

Hypertension and hypokalemia with severe hydronephrosis

A case of suspected primary aldosteronism that was complicated to diagnose because severe hydronephrosis meant the patient's aldosterone-to-renin ratio values were normal.

Bone cement leakage causes intracardiac foreign bodies and PE

Patient presenting with chest tightness and dyspnea after surgery for thoracolumbar vertebral compression fracture. Multi-organ embolism was identified caused by bone cement leakage. 

PVI benefit in symptomatic AF not due to ‘placebo effect’

The beneficial effects of pulmonary vein isolation that have been reported in people with symptomatic AF are not due to a placebo effect.

OGTT superior for cardiovascular risk prediction in people with CAD

Two-hour post-load glucose is better at detecting dysglycemia and predicting cardiovascular events than HbA1c in patients with coronary artery disease.

Infective endocarditis with septic embolization in the brain

This patient presented with right thigh swelling, fever, new-onset left hemiplegia, and seizures 18 months after kidney transplant. Enterococcus faecalis infective endocarditis with metastatic brain abscesses was diagnosed.

Antihypertensive deprescribing may slow cognitive decline in nursing home residents

Strategically reducing or discontinuing antihypertensive medications in older nursing home residents may lessen their cognitive decline.

Obesity-related venous thromboembolism

Obesity is a recognized risk factor for VTE, but what is the current understanding of VTE in people living with obesity, their clinical needs, and the therapeutic challenges they face?

Refsum disease revealed by dilated cardiomyopathy

Symptoms of Refsum disease, such as retinitis pigmentosa, usually present in late childhood and adolescence, but cardiac manifestations are frequent in the late course of the disease.

Understanding the MASLD-CVD relationship

How does MASLD influence cardiovascular health? Discover how the interplay affects traditional risk factors, and how imaging techniques and biomarkers can help diagnosis, management, and prevention of CVD in patients with MASLD. 

TTP after a complicated TAVR procedure

When a patient presents with hemolytic anemia, thrombocytopenia, acute renal failure or neuropsychiatric symptoms after complicated cardiac surgery, TTP should be suspected. Make sure you know how to rapidly diagnose and treat this life-threatening emergency.

Worsening heart failure in a survivor of cancer as a young adult

Severe cardiomyopathy presenting 20 years after anthracycline treatment for non-Hodgkin’s lymphoma during early adulthood. The patient's worsening heart failure was successfully managed with multidrug treatment with add-on vericiguat and ivabradine based on quadruple therapy. 

MicroRNAs in diabetic macroangiopathy

Diabetic macroangiopathy is a leading cause of diabetes-related mortality. Could miRNAs improve the future outlook for diabetes patients? Learn about miRNA biogenesis and their functions in diabetic macroangiopathy to find out.

Recognizing postoperative stress cardiomyopathy

A case of severe stress cardiomyopathy, identified during the postoperative wake-up period, in a patient with scoliosis and pectus excavatum who underwent spinal corrective surgery.

Guidelines: neurological care for ECMO patients

  • Open Access
  • ECMO
  • Review

Patients receiving extracorporeal membrane oxygenation commonly experience major complications, including acute brain injury. How should you monitor these patients to prevent ABI, and manage ABI if it occurs?

MRAs benefit HF patients across ejection fraction phenotypes

Mineralocorticoid receptor antagonists could benefit patients with heart failure across the spectrum of ejection fraction phenotypes.

Metabolic syndrome and bone quality

How do metabolic syndrome, its components, and related diseases impact bone quality, and what is the latest view on the contribution made by bone-derived cytokines?

What part do ketones play in heart failure?

Raised levels of ketone bodies can signal cardiac dysfunction. Could these be a new biomarker for staging of heart failure, or even a therapeutic target?

Modern approaches to pericardiocentesis

An overview of latest advances and future directions for management of pericardial effusions, including use of advanced imaging tools and guidance for managing needs of complex cases such as PAH. 

Semaglutide reduces obesity-related MACE risk despite kidney impairment

SELECT trial shows semaglutide reduces the risk for major adverse cardiovascular events in people with overweight or obesity regardless of kidney function impairment.